Skip to main content
Premium Trial:

Request an Annual Quote

Infectious Disease Firm GeneWeave Raises $12M in Series A Financing Round

NEW YORK (GenomeWeb News) – Infectious disease technology firm GeneWeave Biosciences announced it has raised $12 million in a Series A financing round.

Decheng Capital led the round, joined by existing investors Claremont Creek Ventures and X/Seed Capital. The funds will be used to complete the development, validation, and clearance of the initial test for a platform being developed for detecting infectious diseases, the company said.

Steve Tablak, GeneWeave's CEO, said in a statement that the platform called GeneScout will deliver "an unprecedented combination of simplicity and performance to hospital laboratories seeking to replace traditional microbiology with better performing molecular diagnostics."

The San Jose, Calif.-based company also said that Min Cui, managing director at Decheng is joining its board.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.